3BOULTONA J M, MALIK R A, AREZZO J C,et al. Diabetic somatic neuropathies : a technical review [ J ]. Diabetes Care, 2004,27 : 1458 - 1486.
4FELDMAN E L. Oxidative stress and diabetic neuropathy: a new understanding of an old problem [J ]. J Clin Invest,2003,111 ( 4 ) :431 - 433.
5ZIEGLER D, LUFT D. Clinical trials for drugs against diabetic neuropathy: can we combine scientific needs with clinical practicalities [Jl. Int Rev Neurobiol,2002,50 : 431 -463.
6YAQUB B A, SIDDIQUE A, SULIMANI R. Effects of methylcobalarain on diabetic neuropathy [J]. Clin Neurol Neurosurg, 1992,94 ( 2 ) : 105 - 111.
7DELUIS D A ,FERNANDEZ N ,ARRANZ M L,et al. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2 [J]. J Diabetes Complications, 2005,19( 1 ) :42 -46.
8AMBROSCH A, DTIERKES J, LOBMANN R, et al. Hyperhomocysteinemia and endothelial dysfunction in IDDM [ J ]. Diabet Med,2001, 18:185 - 192.
